Yan Leyfman: Episode 3 of The Translational Edge on Cancer Anticoagulation Is Now Live on Shuf
Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, Medical Correspondent at OncLive, shared Jeremy Bellaiche‘s post on LinkedIn, adding:
“Episode 3 of The Translational Edge is now live on Shuf.
As oncology care becomes more personalized, one critical question remains:
Are we dosing based on evidence—or outdated assumptions?
This episode explores the evolving science of anticoagulation in cancer patients with obesity—and how aligning practice with data can directly impact outcomes.
Translating breakthroughs into impact.
Jeremy Bellaiche, Founder of Shuf, shared a post on LinkedIn:
“Excited to share the episode 3 of The Translational Edge season 2 with Yan Leyfman exclusively on Shuf !
Treating Blood Clots in Cancer Patients with Obesity: Why Dosing Finally Caught Up with Reality.”
Stay updated with Hemostasis Today.
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care
-
Apr 20, 2026, 07:53Maha Othman: Students Bringing Biomedical Chemistry to Life Through a Mini Symposium